 Oncternal Therapeutics, Inc. NASDAQ:ONCT Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer Dr. James Breitmeyer - President and CEO Dr. Salim Yazji - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer Carl Byrnes - Northland Capital Markets Robert Burns - H.C. Wainwright Kumar Raja - Brookline Capital Markets Operator Greetings. 